Literature DB >> 10762129

Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model.

J A Obeso1, M C Rodriguez-Oroz, M Rodriguez, M R DeLong, C W Olanow.   

Abstract

The anatomical and physiological basis of levodopa-induced dyskinesias (LIDs) in patients with Parkinson's disease (PD) is reviewed in the light of the current model for the organization of the basal ganglia. This model, which was developed in the late 1980s, works relatively well in explaining the motor features of PD but, for example, it does not account for why tremor, rigidity, bradykinesia, gait dysfunction and postural instability present to differing degrees in different patients, and may respond differently to levodopa treatment or surgical procedures. Recent information suggests that LIDs develop as a consequence of pulsatile stimulation of dopamine receptors, with consequent dysregulation of genes and proteins in downstream neurons resulting in changes in neuronal firing patterns. A modified model of the basal ganglia in PD patients with LID is proposed, which incorporates more recent clinical and experimental data.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762129

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Neuronal activity in the substantia nigra in the anaesthetized rat has fractal characteristics. Evidence for firing-code patterns in the basal ganglia.

Authors:  M Rodríguez; E Pereda; J González; P Abdala; J A Obeso
Journal:  Exp Brain Res       Date:  2003-05-27       Impact factor: 1.972

3.  Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease.

Authors:  O K Sujith; Carol Lane
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

4.  Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias.

Authors:  Xingxing Jin; Kerstin Schwabe; Joachim K Krauss; Mesbah Alam
Journal:  Exp Brain Res       Date:  2016-01-02       Impact factor: 1.972

Review 5.  A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition.

Authors:  Marjan Jahanshahi; Ignacio Obeso; John C Rothwell; José A Obeso
Journal:  Nat Rev Neurosci       Date:  2015-11-04       Impact factor: 34.870

Review 6.  Rule-based category learning in patients with Parkinson's disease.

Authors:  Amanda Price; J Vincent Filoteo; W Todd Maddox
Journal:  Neuropsychologia       Date:  2009-02-02       Impact factor: 3.139

Review 7.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

Review 8.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

9.  Profile of Mahlon DeLong and Alim Benabid, 2014 Lasker-DeBakey Medical Research awardees.

Authors:  C Warren Olanow; Jose Obeso
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

10.  Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.

Authors:  Pedro Barroso-Chinea; Erwan Bezard
Journal:  Front Neuroanat       Date:  2010-09-14       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.